SCYX SCYNEXIS, Inc. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

SCYNEXIS (SCYX) Stock: Buy, Sell, or Hold?

$3.21
-0.12 (-3.60%) ▼
5d: -8.29% 30d: -17.9% 90d: -36.94%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (60%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$3.45 – $4.28
Position: OVERSOLD
Forward P/E & Valuation
-1.6x CHEAP
vs 1.5x historical avg
Wall Street Target
$32.67
+917.7% upside
Options IV & Volume
33th pct IV
HIGH volume confirmation
Support / Resistance
$3.10 / $4.00
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SCYX shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When SCYX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: SCYX is currently trading at $3.21, which is considered oversold relative to its 30-day fair value range of $3.45 to $4.28. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.6) compared to its historical average (1.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, SCYX is in a downtrend. Immediate support is located at $3.10, while resistance sits at $4.00. Short-term momentum is weak, with the stock down 3.6% recently.

Market Sentiment: SCYX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.67 (+917.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $3.45 - $4.28
Company Quality Score 43/100 (HOLD)
Options IV Signal 33th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 59.6%

Trading Range & Key Levels

30-Day Trading Range $3.45 - $4.28
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$0.80 (25.0%)
Support Level $3.10
Resistance Level $4.00
Current Trend Downtrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Options fairly priced (IV 33th percentile)
  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.6%)
  • BULLISH: Trading 917.7% below Wall St target ($32.67)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.64
Wall Street Target $32.67 (+917.7%)
Revenue Growth (YoY) -82.8%
Profit Margin -53.3%
PE vs Historical -1.6 vs 1.5 CHEAP
Share SCYX Analysis

Share this live SCYX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (SCYX)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary: Bearish sentiment dominates $SCYX on StockTwits with one user expressing frustration towards the management team and calling for their removal. No new news articles were available.
Key Retail Themes: management incompetence bearish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:03 PM ET
Data refreshes hourly during market hours. Next update: 7:03 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SCYX.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
29 analysts
$208 30 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 39 SELL
TEVA
Teva Pharma Industries L…
STRONG BUY
15 analysts
$49 47 HOLD
AMLX
Amylyx Pharmaceuticals I…
STRONG BUY
12 analysts
$43 55 HOLD
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 59 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive SCYX Research Pages
SCYX Technical Chart SCYX Price Prediction SCYX Intrinsic Value DCF SCYX Earnings Date SCYX Investment Advisor SCYX Fair Price Analyzer SCYX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals